Advertisement
Multidisciplinary team to examine radiation therapy combined with immunotherapy
Notable research chosen by Cleveland Clinic Cancer Center staff
New results from the BLASST-1 trial show increases in downstaging and relapse-free survival
Study finds that post-cystectomy mortality and survival is associated with socioeconomic factors
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Physician interviews reveal increasing use of systemic therapy for Ia/mUC
Community-based data help predict patients’ response to immune checkpoint inhibitors
Assessing surgical approaches while identifying new ones
New findings could shape the treatment paradigm for a select group of bladder cancer patients
Screening assay effective across all stages, can identify tissue of origin
Study highlights need for mitigation strategies
Advertisement
Advertisement